KR-esults already obtained suggest that the separate determination of fibrinogen and serum factor concentrations, when compared with the ordinary methods of reporting erythrocyte sedimentation rates, is likely to give information of greater clinical value both in diagnosing and in following the progress of disease.
Renal Clearances of Dextrans of Varying Molecular Weights
By DOUGLAS B. BREWER, M.D.
Department ofPathological Studies, University ofBirmingham THESE studies on the urinary excretion of fractions of dextran of different molecular weights were undertaken with two main objects in view. The first was to get some idea of the rate of urinary loss of dextran when used as a plasma substitute and the second to attempt by using dextrans of known molecular weight to measure the range of permeability of the glomerulus.
The excretion of three fractions of dextran has been studied in rabbits. The average molecular weights of the three fractions were 5,000-10,000, 25,000 and 38,000. Simultaneous creatinine clearances were performed and were taken as a measure of the glomerular filtration rate. From the glomerular filtration rate and the concentration of dextran in the plasma for each ten-minute period the amount of dextran in the volume of plasma filtered was calculated (G). This was plotted against the actual amount of dextran excreted in the urine per minute (U).
In any one fraction of dextran it is probable that the rate of passage across the glomerular membrane will bear a constant ratio to the rate of passage of creatinine and that the rate of passage for dextran will fall with increasing molecular weight. Therefore for any given fraction of dextran the graph should be a straight line even if some of the filtered dextran is reabsorbed by the tubules or some dextran excreted by the tubules, provided this occurs with a constant tubular mass. The slope of the line will depend on the rate of glomerular passage and the point of intercept on whether or not dextran is reabsorbed or excreted by the tubules.
The best fitting lines for the experimental data for each dextran fraction were calculated. The equations for these lines measure the slope and so the rate of glomerular passage and also indicate the amount of dextran reabsorbed or excreted ( Fig. 1 and Table 1 ). From these results it appears that dextran is mainly excreted by glomerular filtration. If any tubular excretion or reabsorption occurs it is relatively small in amount.
It can be calculated that, assuming a glomerular filtration rate of 120 ml. per min., it would require the infusion of 7-2 grammes per hour to maintain a plasma concentration of 2 grammes % of a dextran of 38,000 molecular weight. Such a dextran is, from the experimental results, filtered at about 5 % the rate of creatinine. Assuming a plasma volume of 2-5 litres, then in 4-8 hours after stopping the infusion half the plasma dextran would be lost. The "half-life" of dextran fractions of molecular weights 25,000 and 7,000 would on a similar basis be 1 2 hours and 0*24 hour. Dextran of these molecular weights would be of little value for resuscitation of shocked patients. 1. -The amount of dextran (G) in the volume of plasma equivalent in volume to the glomerular filtrate (as measured by the creatinine clearance) has been calculated and plotted against the urinary excretion of dextran per minute (U). This graph shows the results for the three fractions studied, the fraction of molecular weight 5,000-10,000 by solid dots, that of 25,000 by crosses, and that of 38,000 by open circles. A striking feature of the results is the great effect of molecular size on the rate of movement of dextran across the glomerular membrane.
The membrane may be considered as a simple sieve membrane. All the "pores" of it are as permeable to creatinine, inulin, and glucose as they are to water and so all these substances pass across it at the same rate and their concentrations are the same on either side.
A small number of "pores" are known to be permeable to hemoglobin so there must be a fall in the number of pores permeable to molecules in the range between these two sizes. As the number of pores available for filtration decreases with increase in molecular size, so the area available for filtration and the rate of filtration must fall.
The distribution of pore size will be indicated by the graph obtained by plotting the rate of filtration at the glomerulus as represented by the slope of the line U/G against molecular weight (Fig. 2) . The results are preliminary but they indicate that all the pores are permeable to molecules of weight about 7,000, then there is a rapid fall to 20% permeable at 25,000 and a flattening out of the curve to 6 % permeable to molecules about 38,000.
These results can only apply to dextran which has a markedly asymmetric molecule. Many factors such as molecular shape and charge and changes in glomerular dynamics, e.g. increased filtration fraction may well affect the movement of molecules across the glomerular membrane. We are looking forward to examining these possibilities and to attempting to estimate the range of pore size of the normal and diseased glomerulus in the human subject.
Experiments with Dextran Sulphate as an Anticoagulant By K. WALTON, M.D.
Department of Pathological Studies, University ofBirmingham BERGSTROM demonstrated in 1936 that the sulphuric esters of polysaccharides have a heparin-like anticoagulant activity. It was shown by Astrup et al. (1944 Astrup et al. ( , 1946 ) that certain of these compounds were unsuitable for clinical use because they precipitated fibrinogen, agglutinated platelets and caused death from internal bleeding with large dosages.
Gronwall, Ingelman and Mosimann (1945) synthesized three esters of dextrans of varying molecular weight and reported that these all showed toxic properties similar to those of other sulphonated polysaccharides, and concluded that molecular weight was not an important factor in determining the toxicity of these compounds. From the data later furnished by Ingelman (1947) it was possible to infer that his least toxic preparation was appreciably larger in molecular weight than heparin. Accordingly, a range of compounds extending in molecular weight both above and below those prepared by Ingelman was prepared and examined. It was found that when the starting-material (dextran) was below a certain critical molecular weight, the sulphuric ester prepared from it was free from the undesirable properties described above and no more toxic than heparin itself in experimental animals. This compound is shortly to be submitted to therapeutic trial.
Dextran sulphates.-From Table I it can be seen that the dextran sulphates of molecular weight 35,000 and above behaved differently from those of molecular weight 20,000 and less. The first group (hereafter called "large molecular weight" dextran sulphates) behaved similarly though in varying degree, in causing (1) Precipitation of fibrinogen, (2) Agglutination of platelets, (3) Deposition of granular material in reticulo-endothelial cells. The second group ("Small molecular weight" dextran sulphates) were free from these properties.
Large molecular weight dextran sulphates.-The toxicity of these compounds was found to be dependent upon their tendency to precipitate fibrinogen. When this occurred in plasma in vitro the platelets became adherent to, and entrained in the precipitate, forming clumps. This explained the thrombocytopenia and fibrinogenopenia which occurred in 
